Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990-2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017.
epidemiology
global burden
ischemic heart disease
risk factors
temporal trends
Journal
Clinical epidemiology
ISSN: 1179-1349
Titre abrégé: Clin Epidemiol
Pays: New Zealand
ID NLM: 101531700
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
04
2021
accepted:
04
09
2021
entrez:
29
9
2021
pubmed:
30
9
2021
medline:
30
9
2021
Statut:
epublish
Résumé
To estimate the burden of ischemic heart disease (IHD) stratified by gender, age, geographic location, and social-demographic status for 21 regions across the world from 1990 to 2017. Using the Global Burden of Disease Study (GBD) Results Tool, we extracted data on the incidence, mortality, disability-adjusted life years (DALYs), and age-standardized rates related to IHD, as IHD burden measures. Trend analyzes were conducted for major regions. Risk factors for DALYs (obtained from the GBD comparative risk assessment framework) were also analyzed. Globally, 10.6 million (95% uncertainty interval [UI]: 9.6-11.8) cases of IHD occurred in 2017, with 8.9 million (95%UI:8.8-9.1) IHD-related deaths. Both the age-standardized incidence rate (ASIR) and death rate (ASDR) declined from 1990 to 2017 (percentage change: 27.4% and 30.0%, respectively), with average annual percent change (AAPC) values of -1.2% and -1.3%, respectively. In 2017, the global number of IHD-related DALYs was 170.3 million (95%UI:167.1-174.0), and the middle socio-demographic index (SDI) quintile contributed the most to these DALYs. In most regions, indicators (incidence, mortality, and DALYs) declined steadily with SDI increased. High systolic blood pressure (SBP) was the most significant contributor to the DALYs in most regions, accounting for 118.18 million DALYs in 2017 globally, followed by high low-density lipoprotein cholesterol and a diet low in nuts and seeds (101.78 and 52.86 million, respectively). Even though the trend in IHD morbidity and mortality decreased globally, the IHD burden remains high, particularly in regions with lower SDI. It is necessary to learn successful and effective experience in controlling IHD risks and decreasing health disparities to reduce the IHD burden.
Identifiants
pubmed: 34584461
doi: 10.2147/CLEP.S317787
pii: 317787
pmc: PMC8464307
doi:
Types de publication
Journal Article
Langues
eng
Pagination
859-870Informations de copyright
© 2021 Wang et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Glob Heart. 2012 Dec 1;7(4):315-329
pubmed: 23682350
East Mediterr Health J. 2018 Apr 05;24(1):63-71
pubmed: 29658622
Lancet Glob Health. 2018 Dec;6(12):e1339-e1351
pubmed: 30219317
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Alcohol Alcohol. 2007 Sep-Oct;42(5):465-73
pubmed: 17287207
JAMA. 2004 Mar 10;291(10):1238-45
pubmed: 15010446
Lancet. 2012 Dec 15;380(9859):2063-6
pubmed: 23245602
Cureus. 2020 Jul 23;12(7):e9349
pubmed: 32742886
Popul Health Metr. 2012 Nov 01;10(1):21
pubmed: 23113929
N Engl J Med. 2014 Aug 28;371(9):818-27
pubmed: 25162888
Glob Health Sci Pract. 2018 Oct 10;6(Suppl 1):S18-S28
pubmed: 30305336
Heart. 2018 Jan;104(1):58-66
pubmed: 28883037
Heart. 2008 Jul;94(7):836-43
pubmed: 18552223
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Int J Tuberc Lung Dis. 2008 Jan;12(1):3-7
pubmed: 18173869
Glob Heart. 2013 Dec;8(4):341-8
pubmed: 25690636
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Popul Health Metr. 2012 Jan 06;10:1
pubmed: 22226226
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Eur J Prev Cardiol. 2019 May;26(8):824-835
pubmed: 30739508
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S6-10
pubmed: 25962950
Int J Cardiol. 2004 Oct;97(1):63-8
pubmed: 15336808
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Cardiol Clin. 2017 Feb;35(1):1-12
pubmed: 27886780
Glob Heart. 2014 Mar;9(1):91-9
pubmed: 24977114
BMC Cardiovasc Disord. 2020 Feb 22;20(1):87
pubmed: 32087693
Br Med Bull. 2017 Jan 1;121(1):47-60
pubmed: 28069615
J R Soc Med. 1997 Jan;90(1):23-7
pubmed: 9059377
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Epidemiol Community Health. 2012 Nov;66(11):1079-82
pubmed: 22447959
Tidsskr Nor Laegeforen. 2009 Sep 24;129(18):1871-4
pubmed: 19844280
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
Curr Neurovasc Res. 2021;18(1):150-161
pubmed: 33823779
Lancet Glob Health. 2016 Oct;4(10):e704-13
pubmed: 27568068
Nutrients. 2021 Jan 28;13(2):
pubmed: 33525638
Lancet. 2014 Mar 15;383(9921):999-1008
pubmed: 24084292
MMWR Suppl. 2014 Oct 31;63(4):3-27
pubmed: 25356673
Circ Res. 2016 May 27;118(11):1723-35
pubmed: 27230638
Eur Heart J Qual Care Clin Outcomes. 2020 Oct 05;:
pubmed: 33017008
JAMA Cardiol. 2019 Apr 1;4(4):342-352
pubmed: 30865215
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
J Epidemiol Community Health. 2002 Sep;56(9):702-6
pubmed: 12177089
Heart. 2009 Oct;95(19):1559-60
pubmed: 19628470
Semin Vasc Med. 2002 Nov;2(4):355-68
pubmed: 16222626
Lancet. 2018 Nov 10;392(10159):1995-2051
pubmed: 30496106
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
J Am Coll Cardiol. 2019 Nov 19;74(20):2529-2532
pubmed: 31727292
Glob Heart. 2020 Feb 12;15(1):15
pubmed: 32489788
Popul Health Metr. 2014 May 14;12:14
pubmed: 24982595
Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375
pubmed: 31163980
Circulation. 2016 May 17;133(20):1916-26
pubmed: 27006480
Nutrition. 1998 May;14(5):452-7
pubmed: 9614311